Skip to main content

Life Sciences

  1. Forecasting a virus's next move: antiGen shortlists mutations from the evolutionary tree, and Germinal Multi redesigns antibodies against them

    Monoclonal antibodies were an important early tool against COVID-19, but they lost effect as SARS-CoV-2 mutated, and screening for antibodies that hold across variants struggles to keep up. antiGen learns from mutations already made along a virus's phylogenetic tree rather than from sequences alone, using roughly half a million parameters to forecast plausible next mutations; Germinal Multi tests one antibody design against several versions of a target at once on a computer. Combined, they redesigned BD55-1205, which neutralized XFG but not XFG-Next, into X51, which blocked infection by both in laboratory tests.

  2. bioRxiv

    statLens splits statistical design among code, models and researchers, lifting small-model accuracy from 81.0% to 93.6%

    Differential expression analysis requires settling the model family, primary comparison and sample dependence before fitting, decisions previously left to analysts or to code-writing autonomous agents. statLens assigns data profiling and rule checks to code, study-context interpretation to a language model, and final confirmation to the researcher; across 102 tasks, seven models held 92.5–95.0% accuracy, against 17.5–46.8% for LLM-only inference. Mean accuracy for four small models rose from 81.0% as autonomous agents to 93.6%.

  3. bioRxiv

    FoldMapper breaks inverse folding's circular sequence search: shape-retrieved homologs lift best-of-100 recovery to 60.0% on TED

    Protein inverse folding must design an amino-acid sequence that folds into a given backbone, yet using evolutionary information has required searching a multiple sequence alignment with the very sequence being designed, a circular dependency. FoldMapper instead retrieves structural homologs by shape with Foldseek and accumulates their amino-acid identities, weighted by bit score, into a per-residue structural position-specific frequency profile; a multiscale graph encoder then encodes that profile on a sparse local graph before a denser structure-conditioned message-passing network decodes the sequence. On TED structures it reaches 60.0% best-of-100 sequence recovery, above the 43.2% to 56.3% range of the other tabulated methods, with 20.1% sequence diversity.

  4. bioRxiv

    EnzRef reads reactants and products separately before touching the enzyme, lifting R² by 19.8% on unseen enzymes

    Predicting enzyme turnover numbers (kcat) requires resolving activity differences between reactions of the same enzyme and between enzymes acting on the same reaction. EnzRef splits reaction chemistry into reactant and product conditions, interacts each separately with a frozen protein language model, expresses every conditioned enzyme readout as a deviation from that enzyme's own mean residue response, and recomposes the two responses. On the CatPred-DB source held-out set, mean single-model R² rises from 0.553 for MCKcat to 0.614; on the TurNuP-DB enzyme-unseen subset, R² rises from 0.259 to 0.310, a 19.8% relative gain without target-domain adaptation.

  5. bioRxiv

    SMSTPred types methyltransferase substrates from sequence alone: MCC 0.94 under homology-disjoint splits, ahead of sequence and structure homology search

    SMSTPred is a multi-label classifier that reads the substrate type of SAM-dependent methyltransferases, DNA, RNA, protein or small-molecule metabolite, from protein language model embeddings without structural input. Under cross-validation with non-overlapping homology clusters it reaches a mean MCC of 0.94, above sequence-homology nearest neighbor MMseqs2 at 0.848, structure-homology Foldseek at 0.887 and a profile HMM at 0.519. Applied to 115,850 candidate methyltransferases from 1,249 reference proteomes, its predictions show a higher small-molecule share in plants and Actinomycetota, while the plant expansion mostly follows proteome size.

  6. bioRxiv

    Even ideal artificial variants resist fine-tuning: LAMP shows sequence-to-function models still miss distal effects

    LAMP injects artificial, strong and consistent transcription-factor-motif-perturbing SNVs into personal genome datasets to test whether sequence-to-function models can learn variant effects during fine-tuning. Even with the training set scaled to 12,111 genes and 12,011 such idealized causal SNVs, fine-tuned Enformer still trailed an elastic net baseline given only the SNV genotype on held-out genes and people. The analysis points to two obstacles: pre-trained priors that downweight distal regulatory elements make enhancer-to-gene links hard to strengthen, and sequence context differences between instances of the same motif obscure an otherwise easy-to-learn perturbation pattern.

  7. bioRxiv

    GatorAnchor scores each cell-cell link by cross-modal disagreement, topping mean clustering metrics on ten paired multi-omics datasets

    In single-cell multi-omics integration, molecular layers often disagree about whether two cells are neighbors, yet most methods treat those relations as equally reliable. GatorAnchor folds each modality's uncertainty and the disagreement between modality means into a fused representation, then scores candidate cell relations from RNA similarity, second-modality similarity and shared edge-decoder support, weakening or removing unreliable edges. Across ten paired RNA+ADT and RNA+ATAC datasets it beat nine representative integration methods on mean AMI, NMI, ARI and ACC; keeping the 90% least-unreliable candidate edges raised same-type edge purity in all ten datasets, though graph structure changed differently by dataset.

  8. bioRxiv

    No structure needed first: Spec2Function reads metabolite function straight from tandem mass spectra, lifting explainable cirrhosis peaks past one quarter

    Untargeted metabolomics has long required structural identification before pathway analysis, and incomplete spectral libraries leave many differential peaks outside downstream interpretation. Spec2Function aligns tandem mass spectra with multi-aspect functional text curated from HMDB in a shared space through dual-encoder contrastive learning, so a query spectrum needs no prior structural annotation at inference, and retrieval-augmented generation then produces literature-grounded functional summaries. On liver cirrhosis and a 30-organ macaque aging dataset it covered spectra beyond structural annotation and returned functional modules comparable across species.

  9. bioRxiv

    Protein-design pipelines learn to change course mid-run: IMPRESS reallocates sampling at runtime and solves five-island active sites a fixed cascade misses

    Protein design usually chains diffusion backbone generation, inverse folding and structure prediction into a fixed pipeline whose sampling budget is set before the campaign starts, so filters can only discard candidates and cannot steer sampling toward regions the model stack can reach. IMPRESS makes each design pipeline a stateful object that halts, continues, resamples or branches at runtime from its own accumulated backbones, sequences and folds, with decisions evaluated asynchronously and without global synchronization. On the 41-motif AME enzyme-ligand benchmark, the adaptive workflow returns high-quality solutions for motifs with three or more discontinuous residue islands that the fixed cascade does not solve at all, including better than 40% of five-island motifs.

  10. bioRxiv

    Metabolites as nodes, reactions as hyperedges: HyperGenie predicts essential genes with 13% higher PR-AUC than objective-dependent methods

    Predicting bacterial essential genes has relied on flux balance analysis, which assumes knockout strains still optimize for maximum growth, an assumption that does not always hold. HyperGenie represents the E. coli metabolic network as a directed hypergraph, with metabolites as nodes and reactions as hyperedges, and takes wild-type flux features directly as input, removing the post-knockout optimality assumption. On the iML1515 model under aerobic glucose, its PR-AUC is 13% above the objective-dependent FlowGAT and random forest, and it matches the flux-sampling FCL on comparable gene subsets.